Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...
Pfizer enters the obesity drug market with its Metsera acquisition, aiming to challenge leaders Eli Lilly and Novo Nordisk.
Even with Trump's looming threats to impose tariffs on pharma imports, the performance of AstraZeneca's cardiovascular and ...
Are GLP-1 weight loss drugs the best we can do? Learn why some are pursuing alternatives to appetite suppression.
Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.
Lower eGFRs were associated with higher likelihood of developing kidney failure and death among adults with diabetes, ...
DelveInsight's SGLT2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies ...
The intertwined rise of obesity and type 2 diabetes, termed 'diabesity,' presents a significant health challenge in India. This condition, driven by complex factors beyond lifestyle, faces stigma ...
(CNN) — This week, officials confirmed 21 cases of Legionnaires' disease and one death in Marshall County. This comes after an outbreak this summer in New York that led to seven deaths and 114 ...